Moreover, several studies showed that GHET1 was involved in regulating epithelial-mesenchymal transition process in hepatocellular carcinoma [13], breast cancer [15], colorectal cancer [16], esophageal squamous cell carcinoma [17], bladder cancer [19], and osteosarcoma [21]. The gene discussed is GHET1; the disease is breast cancer.